Bayer Association of Clinical Characteristics and Genetic Alterations with NTRK Fusions: Phase II and III Patient-Level Analysis: for clinical outcomes data and patient level data
|Effective start/end date||7/26/23 → 12/31/24|
- THE UNIVERSITY OF UTAH
- BAYER HEALTHCARE PHARMACEUTICALS
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.